Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lauren Beacham"'
Autor:
Kempapura Murthy, Sarah Spencer, Holly C Groom, Sara S Kim, Laura J. Edwards, Zuha Jeddy, Lauren Beacham, F. Liaini Gross, Fatimah S. Dawood, Edward A. Belongia, Shivaprakash Gangappa, Allison L. Naleway, Meredith G Wesley, Min Z. Levine, Sarah Ball, Margarita Mishina, Mark G. Thompson, Suryaprakash Sambhara, Danielle R. Hunt, Weiping Cao, Alicia M. Fry, Manjusha Gaglani, Brendan Flannery, Kelsey R. Bounds
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background RIV4 and cell-culture based inactivated influenza vaccine (ccIIV4) have not been compared to egg-based IIV4 in healthcare personnel, a population with frequent influenza vaccination that may blunt vaccine immune responses over time. We con
Autor:
Arnold S. Monto, Joshua D. Doyle, Emily R Smith, Brendan Flannery, Donald B Middleton, Fernanda P. Silveira, Lauren Beacham, Emily T. Martin, Richard K. Zimmerman, Melissa A Rolfes, H. Keipp Talbot, Jill M. Ferdinands, Manjusha Gaglani, Elif Alyanak
Publikováno v:
Clin Infect Dis
Background Seasonal influenza causes substantial morbidity and mortality in older adults. High-dose inactivated influenza vaccine (HD-IIV), with increased antigen content compared to standard-dose influenza vaccines (SD-IIV), is licensed for use in p
Autor:
Alicia M. Fry, William G. Davis, Min Z. Levine, Angela P Campbell, Kathryn E. Lafond, Melissa A Rolfes, Lauren Beacham, Eduardo Azziz-Baumgartner, Sarah Spencer, Mark G. Thompson, Manish M. Patel
Publikováno v:
Vaccine. 38:608-619
Identifying optimal priming strategies for children2 years could substantially improve the public health benefits of influenza vaccines. Adjuvanted seasonal influenza vaccines were designed to promote a better immune response among young vaccine-naï
Autor:
Alicia P Budd, Lauren Beacham, Krista Kniss, Min Z. Levine, Alicia M. Fry, Catherine B. Smith, Shikha Garg, Rebecca Garten, Farida B. Ahmad, Charisse N Cummings, Lynnette Brammer, Desiree Mustaquim, Carrie Reed
Publikováno v:
J Infect Dis
Background The evolution of influenza A viruses results in birth cohorts that have different initial influenza virus exposures. Historically, A/H3 predominant seasons have been associated with more severe influenza-associated disease; however, since
Autor:
Weiping Cao, James Stevens, Shivaprakash Gangappa, Shikha Garg, Sonja J Olsen, Justine S. Liepkalns, Timothy H. Holtz, Margarita Mishina, Marcel E. Curlin, Fatimah S. Dawood, Samuel Amoah, Prabda Praphasiri, Suryaprakash Sambhara, Paul J. Carney, Jin Hyang Kim, Jessie C. Chang, Lauren Beacham, Zhu Guo, Stefan Fernandez
Publikováno v:
The Journal of Infectious Diseases. 220:743-751
Background Human immunodeficiency virus (HIV)–infected persons are at a higher risk of severe influenza. Although we have shown that a standard-dose intradermal influenza vaccine versus a standard-dose intramuscular influenza vaccine does not resul
Autor:
Emily DeFranco, Ardythe L. Morrow, Barbara H. Bardenheier, Angela P Campbell, Alexandra M Piasecki, Allison Cline, Lauren Beacham, Brady J. Gelvin, Elizabeth P. Schlaudecker, Daniel C. Payne, Shannon C. Conrey, Mary Allen Staat
Publikováno v:
Open Forum Infectious Diseases
Background The ACIP recommends influenza and Tdap vaccination during pregnancy to reduce the risk of influenza and pertussis in the mother and her infant. We assessed influenza and Tdap vaccination coverage and associated factors among pregnant women
Autor:
Monica M. McNeal, Daniel C. Payne, Mary Allen Staat, Leila C. Sahni, Janet A. Englund, Joana Y Lively, Geoffrey A. Weinberg, Manish M. Patel, Craig J. McGowan, Eileen J. Klein, Peter G. Szilagyi, Lauren Beacham, Marian G. Michaels, John V. Williams, Constance Ogokeh, Natasha B. Halasa, Angela P Campbell, Julie A. Boom, Rangaraj Selvarangan, Christopher J. Harrison, Brian Rha, Laura S Stewart, Alicia M. Fry
Publikováno v:
Open Forum Infectious Diseases
Background Annual national estimates of influenza vaccine effectiveness (VE) typically measure protection against outpatient medically attended influenza illness. We assessed influenza VE in preventing laboratory-confirmed influenza hospitalization i
Autor:
Mary Allen Staat, Barbara H. Bardenheier, Janet A. Englund, John V. Williams, Lauren Beacham, Alicia M. Fry, Christopher J. Harrison, Julie A. Boom, Constance Ogokeh, Angela P Campbell, Rangaraj Selvarangan, Geoffrey A. Weinberg, Laura S Stewart, Manish M. Patel, Eileen J. Klein, Leila C. Sahni, Daniel C. Payne, Peter G. Szilagyi, Brian Rha, Marian G. Michaels, Joana Y Lively, Elizabeth P. Schlaudecker, Natasha B. Halasa
Publikováno v:
Open Forum Infectious Diseases
Background Influenza vaccination has been shown to reduce influenza risk in pregnant women and their infants who are not yet age-eligible for vaccine. Ascertainment of vaccination history is important for vaccine safety and effectiveness evaluations.
Autor:
Art Reingold, Alison Muse, Alissa O’Halloran, Ruth Lynfield, Maya Monroe, Laurie M Billing, Evan J. Anderson, Kim Yousey-Hindes, Carrie Reed, Lourdes Irizarry, Carmen S. Arriola, Keipp Talbot, Lauren Beacham, Charisse N Cummings, Nancy M. Bennett, Sue Kim, Nisha B Alden, Keegan McCaffrey, Alicia M. Fry, Ann Thomas, Shikha Garg
Publikováno v:
Open Forum Infectious Diseases
Background Influenza vaccination may reduce illness severity among those with influenza; however, data are limited. We determined whether outcomes were less severe among vaccinated compared with unvaccinated adults hospitalized with influenza over 5
Autor:
Elif Alyanak, Fernanda P. Silveira, Don Middleton, H. Keipp Talbot, Lauren Beacham, Jill M. Ferdinands, Emily T. Martin, Brendan Flannery, Manjusha Gaglani, Richard K. Zimmerman, Joshua D. Doyle
Publikováno v:
Open Forum Infectious Diseases
Background Seasonal influenza causes substantial morbidity and mortality, and older adults are disproportionately affected. Newer vaccines have been developed for use in people 65 years and older, including a trivalent inactivated vaccine with a 4-fo